January 10, 2017
Novo Nordisk A/S – Share repurchase programme
On 28 October 2016, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
January 10, 2017
IT provider for healthcare market Instem names new COO
An IT provider for healthcare market Instem, has appointed MaryBeth Thompson as Chief Operating Officer of the Group. Thompson has not been appointed to the company’s main Board, and she will report to Phil Reason, CEO.
January 10, 2017
Oxular Limited, a retinal therapeutics company, has promoted David Fellows, previously Non-Executive Director, as the Company’s Chairman of the Board. Fellows will replace Dr. Nigel Pitchford, who will continue on Oxular’s Board as a Director.
January 9, 2017
Innate Pharma cashes $15million milestone payment from Bristol-Myers for lirilumab-Opdivo testing
Bristol-Myers Squibb (BMS) has reached a payment milestone in connection with the licensing deal with Innate Pharma for lirilumab in combination with Opdivo. BMS has paied Innate $15 million.
January 9, 2017
Swedish drugmaker Sobi wants its new CEO from Europe, Geoffrey McDonough to leave in July
Sweden-based pharmaceutical company Orphan Biovitrum AB (Sobi) has began looking for the new Chief Executive Officer (CEO), presumably a residence of Europe. The company said on Monday that its current boss, Geoffrey McDonough will leave the company in six months, on July 1, 2017.
January 9, 2017
Takeda notifies 4.48% shareholding in TiGenix
On January 4, 2017, TiGenix received a transparency notification from related companies Takeda Pharmaceutical Company Limited/Takeda Pharmaceuticals International AG, following…
January 9, 2017
Argenx starts Phase II study of myasthenia gravis drug
Argenx, a European biopharmaceutical company focused on drugs for the treatment of cancer and autoimmune diseases, has initiated a Phase…
January 9, 2017
Celyad’s patent holds up after being challenged by third party
U.S. Patent and Trade Office (USPTO) has decided to uphold Celyad’s U.S. Patent No. 9,181,527, relating to allogeneic human primary…
January 9, 2017
Why study Bioscience?
Author: Anna Michael, The Study Abroad Portal The Study Abroad Portal helps students worldwide to make the right decision with…
January 9, 2017
Ipsen buys Merrimack’s oncology assets
Ipsen has acquired global oncology assets from Merrimack Pharmaceuticals. This acquisition includes Merrimack’s key marketed product Onivyde (irinotecan liposome injection)…